{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:13:10Z","timestamp":1792836790750,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:00:00Z","timestamp":1454025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM097245"],"award-info":[{"award-number":["R01 GM097245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA140458"],"award-info":[{"award-number":["R01 CA140458"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA014520"],"award-info":[{"award-number":["P30 CA014520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008692"],"award-info":[{"award-number":["T32GM008692"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2083-x","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T10:15:32Z","timestamp":1454062532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Ryan A.","family":"Denu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Zasadil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Kanugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Laffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Burkard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"issue":"6","key":"2083_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm2180","volume":"8","author":"M Bettencourt-Dias","year":"2007","unstructured":"Bettencourt-Dias M, Glover DM. Centrosome biogenesis and function: centrosomics brings new understanding. Nat Rev Mol Cell Biol. 2007;8(6):451\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"2083_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tig.2011.05.004","volume":"27","author":"M Bettencourt-Dias","year":"2011","unstructured":"Bettencourt-Dias M, Hildebrandt F, Pellman D, Woods G, Godinho SA. Centrosomes and cilia in human disease. Trends Genet. 2011;27(8):307\u201315.","journal-title":"Trends Genet"},{"issue":"8","key":"2083_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/ijbs.7.1122","volume":"7","author":"JY Chan","year":"2011","unstructured":"Chan JY. A clinical overview of centrosome amplification in human cancers. Int J Biol Sci. 2011;7(8):1122\u201344.","journal-title":"Int J Biol Sci"},{"issue":"Suppl 1","key":"2083_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/jcs.025742","volume":"121","author":"T Boveri","year":"2008","unstructured":"Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci. 2008;121 Suppl 1:1\u201384.","journal-title":"J Cell Sci"},{"key":"2083_CR5","doi-asserted-by":"publisher","first-page":"20130467","DOI":"10.1098\/rstb.2013.0467","volume":"369","author":"SA Godinho","year":"2014","unstructured":"Godinho SA, Pellman D. Causes and consequences of centrosome abnormalities in cancer. Philos Trans R Soc Lond B Biol Sci. 2014;369:20130467.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"6","key":"2083_CR6","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1073\/pnas.95.6.2950","volume":"95","author":"WL Lingle","year":"1998","unstructured":"Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc Natl Acad Sci U S A. 1998;95(6):2950\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2083_CR7","first-page":"1398","volume":"63","author":"GA Pihan","year":"2003","unstructured":"Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 2003;63(6):1398\u2013404.","journal-title":"Cancer Res"},{"issue":"3","key":"2083_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/0008-5472.CAN-03-2451","volume":"64","author":"U Kronenwett","year":"2004","unstructured":"Kronenwett U, Huwendiek S, Ostring C, Portwood N, Roblick UJ, Pawitan Y, et al. Improved grading of breast adenocarcinomas based on genomic instability. Cancer Res. 2004;64(3):904\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"2083_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/A:1016550619925","volume":"75","author":"AB D\u2019Assoro","year":"2002","unstructured":"D\u2019Assoro AB, Barrett SL, Folk C, Negron VC, Boeneman K, Busby R, et al. Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res Treat. 2002;75(1):25\u201334.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2083_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/ijc.11408","volume":"107","author":"A Schneeweiss","year":"2003","unstructured":"Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K, Krause U, et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer. 2003;107(3):346\u201352.","journal-title":"Int J Cancer"},{"issue":"12","key":"2083_CR11","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-09-4094","volume":"70","author":"R Bagheri-Yarmand","year":"2010","unstructured":"Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi K. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res. 2010;70(12):5074\u201384.","journal-title":"Cancer Res"},{"issue":"4","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1186\/bcr1752","volume":"9","author":"HQ Guo","year":"2007","unstructured":"Guo HQ, Gao M, Ma J, Xiao T, Zhao LL, Gao Y, et al. Analysis of the cellular centrosome in fine-needle aspirations of the breast. Breast Cancer Res. 2007;9(4):R48.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"2083_CR13","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.18632\/oncotarget.3402","volume":"6","author":"V Pannu","year":"2015","unstructured":"Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, et al. Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers. Oncotarget. 2015;6(12):10487\u201397.","journal-title":"Oncotarget"},{"issue":"17","key":"2083_CR14","first-page":"3974","volume":"58","author":"GA Pihan","year":"1998","unstructured":"Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998;58(17):3974\u201385.","journal-title":"Cancer Res"},{"issue":"2","key":"2083_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P","volume":"27","author":"BM Ghadimi","year":"2000","unstructured":"Ghadimi BM, Sackett DL, Difilippantonio MJ, Schr\u00f6ck E, Neumann T, Jauho A, et al. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer. 2000;27(2):183\u201390.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"2083_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrc2781","volume":"10","author":"JM Schvartzman","year":"2010","unstructured":"Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer. 2010;10(2):102\u201315.","journal-title":"Nat Rev Cancer"},{"key":"2083_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/B978-0-12-387688-1.00003-X","volume":"112","author":"JM Nicholson","year":"2011","unstructured":"Nicholson JM, Cimini D. How mitotic errors contribute to karyotypic diversity in cancer. Adv Cancer Res. 2011;112:43\u201375.","journal-title":"Adv Cancer Res"},{"key":"2083_CR18","unstructured":"Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer [ http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman ]"},{"issue":"5","key":"2083_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ncb2958","volume":"16","author":"H Maiato","year":"2014","unstructured":"Maiato H, Logarinho E. Mitotic spindle multipolarity without centrosome amplification. Nat Cell Biol. 2014;16(5):386\u201394.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2083_CR20","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ng1449","volume":"36","author":"S Hanks","year":"2004","unstructured":"Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet. 2004;36(11):1159\u201361.","journal-title":"Nat Genet"},{"issue":"5706","key":"2083_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1126\/science.1104905","volume":"307","author":"NJ Quintyne","year":"2005","unstructured":"Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS. Spindle multipolarity is prevented by centrosomal clustering. Science. 2005;307(5706):127\u20139.","journal-title":"Science"},{"issue":"4","key":"2083_CR22","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1073\/pnas.032479999","volume":"99","author":"WL Lingle","year":"2002","unstructured":"Lingle WL, Barrett SL, Negron VC, D\u2019Assoro AB, Boeneman K, Liu W, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A. 2002;99(4):1978\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2083_CR23","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.cub.2012.06.057","volume":"22","author":"MR Mahjoub","year":"2012","unstructured":"Mahjoub MR, Stearns T. Supernumerary centrosomes nucleate extra cilia and compromise primary cilium signaling. Curr Biol. 2012;22(17):1628\u201334.","journal-title":"Curr Biol"},{"issue":"7503","key":"2083_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nature13277","volume":"510","author":"SA Godinho","year":"2014","unstructured":"Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, et al. Oncogene-like induction of cellular invasion from centrosome amplification. Nature. 2014;510(7503):167\u201371.","journal-title":"Nature"},{"issue":"3","key":"2083_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1023\/B:JOMG.0000048774.27697.30","volume":"9","author":"JL Salisbury","year":"2004","unstructured":"Salisbury JL, D\u2019Assoro AB, Lingle WL. Centrosome amplification and the origin of chromosomal instability in breast cancer. J Mammary Gland Biol Neoplasia. 2004;9(3):275\u201383.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"2083_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","volume":"25","author":"L Wang","year":"2014","unstructured":"Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, et al. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell. 2014;25(1):21\u201336.","journal-title":"Cancer Cell"},{"issue":"1","key":"2083_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1535-7163.MCT-15-0527","volume":"15","author":"A Choudhary","year":"2016","unstructured":"Choudhary A, Zachek B, Lera RF, Zasadil LM, Lasek A, Denu RA, Kim H, Kanugh C, Laffin JJ, Harter JM et al: Identification of selective lead compounds for treatment of high-ploidy breast cancer. Mol Cancer Ther. 2016;15(1):48\u201359.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2083_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10549-012-2067-8","volume":"135","author":"R Nahta","year":"2012","unstructured":"Nahta R, O\u2019Regan RM. Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers. Breast Cancer Res Treat. 2012;135(1):39\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2083_CR29","first-page":"2435","volume":"10","author":"RJ Pietras","year":"1995","unstructured":"Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, et al. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene. 1995;10(12):2435\u201346.","journal-title":"Oncogene"},{"issue":"2","key":"2083_CR30","first-page":"425","volume":"59","author":"A Wolff","year":"1992","unstructured":"Wolff A, de N\u00e9chaud B, Chillet D, Mazarguil H, Desbruy\u00e8res E, Audebert S, et al. Distribution of glutamylated alpha and beta-tubulin in mouse tissues using a specific monoclonal antibody, GT335. Eur J Cell Biol. 1992;59(2):425\u201332.","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"2083_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5","volume":"39","author":"Y Bobinnec","year":"1998","unstructured":"Bobinnec Y, Moudjou M, Fouquet JP, Desbruy\u00e8res E, Edd\u00e9 B, Bornens M. Glutamylation of centriole and cytoplasmic tubulin in proliferating non-neuronal cells. Cell Motil Cytoskeleton. 1998;39(3):223\u201332.","journal-title":"Cell Motil Cytoskeleton"},{"issue":"4","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0092-8674(94)90504-5","volume":"76","author":"SJ Doxsey","year":"1994","unstructured":"Doxsey SJ, Stein P, Evans L, Calarco PD, Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell. 1994;76(4):639\u201350.","journal-title":"Cell"},{"issue":"32","key":"2083_CR33","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1073\/pnas.1308203110","volume":"110","author":"A Choudhary","year":"2013","unstructured":"Choudhary A, Lera RF, Martowicz ML, Oxendine K, Laffin JJ, Weaver BA, et al. Interphase cytofission maintains genomic integrity of human cells after failed cytokinesis. Proc Natl Acad Sci U S A. 2013;110(32):13026\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2083_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"29","key":"2083_CR35","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","volume":"23","author":"JD Brenton","year":"2005","unstructured":"Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005;23(29):7350\u201360.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2083_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1083\/jcb.94.3.549","volume":"94","author":"D Ring","year":"1982","unstructured":"Ring D, Hubble R, Kirschner M. Mitosis in a cell with multiple centrioles. J Cell Biol. 1982;94(3):549\u201356.","journal-title":"J Cell Biol"},{"issue":"16","key":"2083_CR37","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1101\/gad.1700908","volume":"22","author":"M Kwon","year":"2008","unstructured":"Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev. 2008;22(16):2189\u2013203.","journal-title":"Genes Dev"},{"issue":"2","key":"2083_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst SM, McGranahan N, Burrell RA, Rowan AJ, Gr\u00f6nroos E, Endesfelder D, et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014;4(2):175\u201385.","journal-title":"Cancer Discov"},{"issue":"7252","key":"2083_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature08136","volume":"460","author":"NJ Ganem","year":"2009","unstructured":"Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460(7252):278\u201382.","journal-title":"Nature"},{"issue":"8","key":"2083_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/em.20532","volume":"50","author":"MJ Difilippantonio","year":"2009","unstructured":"Difilippantonio MJ, Ghadimi BM, Howard T, Camps J, Nguyen QT, Ferris DK, et al. Nucleation capacity and presence of centrioles define a distinct category of centrosome abnormalities that induces multipolar mitoses in cancer cells. Environ Mol Mutagen. 2009;50(8):672\u201396.","journal-title":"Environ Mol Mutagen"},{"issue":"4","key":"2083_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2014.06.029","volume":"158","author":"NJ Ganem","year":"2014","unstructured":"Ganem NJ, Cornils H, Chiu SY, O\u2019Rourke KP, Arnaud J, Yimlamai D, et al. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell. 2014;158(4):833\u201348.","journal-title":"Cell"},{"issue":"6","key":"2083_CR42","doi-asserted-by":"publisher","first-page":"e20701","DOI":"10.1371\/journal.pone.0020701","volume":"6","author":"A Kumar","year":"2011","unstructured":"Kumar A, Gao H, Xu J, Reuben J, Yu D, Mehta K. Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells. PLoS One. 2011;6(6):e20701.","journal-title":"PLoS One"},{"issue":"7","key":"2083_CR43","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2083_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo S, Vieira AF, Gerhard R, Leit\u00e3o D, Pinto R, Cameselle-Teijeiro JF, et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol. 2011;64(11):937\u201346.","journal-title":"J Clin Pathol"},{"issue":"5","key":"2083_CR45","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr1610","volume":"8","author":"C Sheridan","year":"2006","unstructured":"Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, et al. CD44+\/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006;8(5):R59.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2083_CR46","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1167\/iovs.02-1225","volume":"44","author":"CS Alge","year":"2003","unstructured":"Alge CS, Suppmann S, Priglinger SG, Neubauer AS, May CA, Hauck S, et al. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci. 2003;44(8):3629\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2083_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1350-9462(98)00001-9","volume":"17","author":"T Kivel\u00e4","year":"1998","unstructured":"Kivel\u00e4 T, Uusitalo M. Structure, development and function of cytoskeletal elements in non-neuronal cells of the human eye. Prog Retin Eye Res. 1998;17(3):385\u2013428.","journal-title":"Prog Retin Eye Res"},{"issue":"Pt 2","key":"2083_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1242\/jcs.91.2.303","volume":"91","author":"NM McKechnie","year":"1988","unstructured":"McKechnie NM, Boulton M, Robey HL, Savage FJ, Grierson I. The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo. J Cell Sci. 1988;91(Pt 2):303\u201312.","journal-title":"J Cell Sci"},{"key":"2083_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/3-540-27152-X_7","volume-title":"Vitreo-retinal Surgery","author":"C Sheridan","year":"2005","unstructured":"Sheridan C, Hiscott P, Grierson I. Retinal Pigment Epithelium Differentiation and Dedifferentiation. In: Kirchhof B, Wong D, editors. Vitreo-retinal Surgery. 2005. p. 101\u201319."},{"issue":"10","key":"2083_CR50","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1200\/JCO.2000.18.10.2059","volume":"18","author":"JF Simpson","year":"2000","unstructured":"Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, Gilchrist KW, et al. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol. 2000;18(10):2059\u201369.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2083_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403\u201310.","journal-title":"Histopathology"},{"issue":"24","key":"2083_CR52","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1101\/gad.207027.112","volume":"26","author":"AJ Holland","year":"2012","unstructured":"Holland AJ, Fachinetti D, Zhu Q, Bauer M, Verma IM, Nigg EA, et al. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle. Genes Dev. 2012;26(24):2684\u20139.","journal-title":"Genes Dev"},{"issue":"6","key":"2083_CR53","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.cell.2008.05.039","volume":"133","author":"R Basto","year":"2008","unstructured":"Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A, et al. Centrosome amplification can initiate tumorigenesis in flies. Cell. 2008;133(6):1032\u201342.","journal-title":"Cell"},{"issue":"6","key":"2083_CR54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0002-9440(10)65513-7","volume":"155","author":"WL Lingle","year":"1999","unstructured":"Lingle WL, Salisbury JL. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am J Pathol. 1999;155(6):1941\u201351.","journal-title":"Am J Pathol"},{"issue":"3","key":"2083_CR55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00432-008-0472-5","volume":"135","author":"A Shimomura","year":"2009","unstructured":"Shimomura A, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Association of loss of BRCA1 expression with centrosome aberration in human breast cancer. J Cancer Res Clin Oncol. 2009;135(3):421\u201330.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2083_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0962-8924(00)01872-9","volume":"11","author":"BR Brinkley","year":"2001","unstructured":"Brinkley BR. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 2001;11(1):18\u201321.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"2083_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ccr.2014.05.006","volume":"26","author":"JM Mason","year":"2014","unstructured":"Mason JM, Lin DC, Wei X, Che Y, Yao Y, Kiarash R, et al. Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent. Cancer Cell. 2014;26(2):163\u201376.","journal-title":"Cancer Cell"},{"issue":"1","key":"2083_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/jm5005336","volume":"58","author":"PB Sampson","year":"2015","unstructured":"Sampson PB, Liu Y, Forrest B, Cumming G, Li SW, Patel NK, et al. The discovery of Polo-like kinase 4 inhibitors: identification of (1R,2S).2-(3-((E).4-(((cis).2,6-dimethylmorpholino)methyl)styryl). 1H.indazol-6-yl)-5\u2032-methoxyspiro[cyclopropane-1,3\u2032-indolin]-2\u2032-one (CFI-400945) as a potent, orally active antitumor agent. J Med Chem. 2015;58(1):147\u201369.","journal-title":"J Med Chem"},{"issue":"6239","key":"2083_CR59","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.aaa5111","volume":"348","author":"YL Wong","year":"2015","unstructured":"Wong YL, Anzola JV, Davis RL, Yoon M, Motamedi A, Kroll A, et al. Reversible centriole depletion with an inhibitor of Polo-like kinase 4. Science. 2015;348(6239):1155\u201360.","journal-title":"Science"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2083-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2083-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2083-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T15:44:32Z","timestamp":1654184672000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2083-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2083-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]},"assertion":[{"value":"24 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}